Encompass Health (EHC) EBIT (2009 - 2026)

Encompass Health (EHC) has 18 years of EBIT data on file, last reported at $59.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 20.61% year-over-year to $59.7 million; the trailing twelve-month figure through Mar 2026 stood at -$147.2 million (down 236.55% YoY), and the FY2025 full-year result was $164.4 million, up 165.59% from the prior year.
• EBIT for Q1 2026 stood at $59.7 million, up from -$415.4 million in the prior quarter.
• Across five years, EBIT topped out at $505.9 million in Q4 2023 and bottomed at -$415.4 million in Q4 2025.
• The 5-year median for EBIT is $12.5 million (2025), against an average of $20.7 million.
• The widest annual swing landed in 2024, when EBIT jumped 21185.71%; it then plunged 1703.86% in 2025.
• A 5-year view of EBIT shows it stood at -$342.5 million in 2022, then jumped by 247.71% to $505.9 million in 2023, then tumbled by 94.88% to $25.9 million in 2024, then slumped by 1703.86% to -$415.4 million in 2025, then surged by 114.37% to $59.7 million in 2026.
• The last three EBIT figures came in at $59.7 million (Q1 2026), -$415.4 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.

Peer Comparison